Enabling biotech with strategic AI

The biotech industry is undergoing an AI-enabled transformation that is remodeling both the science and the business models that drive drug development. These changes create new opportunities for innovation and value realization but also pose uncertainty and risks. Successfully navigating this transition will require blending strategic insight with technical AI expertise to ensure that AI is driving value where it matters most.

Coescent operates at the intersection of technical, scientific, and commercial strategy, helping biotech companies develop cohesive internal and external-facing AI strategies that optimize for their core value propositions and introduce new value creation opportunities. This includes strategic innovation, integration, and partnering across the spectrum of structural, cellular, and agentic AI, as well as translation of technical differentiation into market strategy for AI-first companies operating in biopharma. For more on Coescent solution areas see Solution Areas.